A new trading day began on Monday, with Soleno Therapeutics Inc (NASDAQ: SLNO) stock price up 20.16% from the previous day of trading, before settling in for the closing price of $37.89. SLNO’s price has ranged from $3.16 to $53.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 33.76%. With a float of $20.31 million, this company’s outstanding shares have now reached $31.68 million.
In an organization with 42 employees, it is important to assess its efficiency.
Soleno Therapeutics Inc (SLNO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Soleno Therapeutics Inc is 39.22%, while institutional ownership is 58.30%. The most recent insider transaction that took place on Apr 01 ’24, was worth 784,645. In this transaction CHIEF EXECUTIVE OFFICER of this company sold 18,980 shares at a rate of $41.34, taking the stock ownership to the 152,790 shares. Before that another transaction happened on Apr 01 ’24, when Company’s CHIEF FINANCIAL OFFICER sold 5,175 for $41.34, making the entire transaction worth $213,937. This insider now owns 62,953 shares in total.
Soleno Therapeutics Inc (SLNO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 33.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.00% during the next five years compared to 24.34% growth over the previous five years of trading.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Here are Soleno Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -0.75 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.93 million. That was better than the volume of 0.34 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.52%. Additionally, its Average True Range was 2.94.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 68.78%, which indicates a significant increase from 51.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 96.08% in the past 14 days, which was higher than the 62.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.16, while its 200-day Moving Average is $28.63. However, in the short run, Soleno Therapeutics Inc’s stock first resistance to watch stands at $51.33. Second resistance stands at $57.13. The third major resistance level sits at $60.46. If the price goes on to break the first support level at $42.20, it is likely to go to the next support level at $38.87. Assuming the price breaks the second support level, the third support level stands at $33.07.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
With a market capitalization of 1.52 billion, the company has a total of 33,411K Shares Outstanding. Currently, annual sales are 0 K while annual income is -38,990 K. The company’s previous quarter sales were 0 K while its latest quarter income was -11,300 K.
